Utama › COPD
Kajian klinikal COPD sedang mengambil peserta di AS
98 kajian untuk COPD sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Philadelphia, PA23 kajian
- Miami, FL18 kajian
- Birmingham, AL17 kajian
- Boston, MA17 kajian
- Houston, TX15 kajian
- Orlando, FL15 kajian
- Baltimore, MD14 kajian
- Chicago, IL14 kajian
- Dallas, TX12 kajian
- Pittsburgh, PA12 kajian
- New York City, NY11 kajian
- Ann Arbor, MI10 kajian
- Winston-Salem, NC9 kajian
- Detroit, MI9 kajian
- Los Angeles, CA9 kajian
- Phoenix, AZ9 kajian
- Kansas City, KS9 kajian
- Charlotte, NC9 kajian
- Hialeah, FL8 kajian
- Newport Beach, CA8 kajian
- Columbus, OH8 kajian
- Cleveland, OH8 kajian
- Nashville, TN7 kajian
- Tampa, FL7 kajian
- Durham, NC7 kajian
- Kendall, FL7 kajian
- Denver, CO7 kajian
- Milwaukee, WI7 kajian
- Farmington Hills, MI6 kajian
- Jacksonville, FL6 kajian
- West Palm Beach, FL6 kajian
- Indianapolis, IN6 kajian
- Aurora, CO6 kajian
- Las Vegas, NV5 kajian
- St. Louis, MO5 kajian
- Shreveport, LA5 kajian
- El Paso, TX5 kajian
- Rapid City, SD5 kajian
- Baton Rouge, LA5 kajian
- Spartanburg, SC5 kajian
Mengikut negeri
- Alabama21 kajian
- Arizona17 kajian
- California26 kajian
- Colorado15 kajian
- Connecticut3 kajian
- Florida28 kajian
- Georgia12 kajian
- Idaho4 kajian
- Illinois19 kajian
- Indiana10 kajian
- Iowa6 kajian
- Kansas12 kajian
- Kentucky5 kajian
- Louisiana9 kajian
- Maine3 kajian
- Maryland16 kajian
- Massachusetts25 kajian
- Michigan22 kajian
- Minnesota11 kajian
- Mississippi3 kajian
- Missouri7 kajian
- Montana3 kajian
- Nebraska5 kajian
- Nevada8 kajian
- New Jersey7 kajian
- New York19 kajian
- North Carolina22 kajian
- Ohio17 kajian
- Oklahoma8 kajian
- Oregon6 kajian
- Pennsylvania33 kajian
- South Carolina14 kajian
- South Dakota6 kajian
- Tennessee14 kajian
- Texas25 kajian
- Utah6 kajian
- Vermont5 kajian
- Virginia12 kajian
- Washington6 kajian
- West Virginia5 kajian
- Wisconsin8 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06283966Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
Mengambil peserta
Umur 40 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07072039Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07190222WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07558265To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Mengambil pesertaFasa 2
Umur 40 hingga 85 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07684820Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
Mengambil peserta
Umur 40 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05934565A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
Mengambil pesertaFasa 2
Umur 40 hingga 80 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07725939A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07780656: Vascular Function in Health and Disease
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT02966665A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Mengambil pesertaFasa 2
Umur 40 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Mengambil pesertaFasa 4
Umur 40 hingga 85 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07053423A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Mengambil peserta
Umur 40 hingga 80 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Mengambil pesertaFasa 2
Umur 40 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07646587Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
Mengambil pesertaFasa 4
Umur 60 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07816835A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06603246COPD Exacerbation Follow Up
Mengambil pesertaKajian pemerhatian
Umur 40 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07118306The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
Mengambil pesertaKajian pemerhatian
Umur 40 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Mengambil pesertaFasa 2/3
Umur 35 hingga 80 · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT07363694Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.